💵 Femtech Investors in Hong Kong

Hong Kong's femtech ecosystem was established less than five years ago, making it a small but rapidly growing sector with leading categories currently being addressed including: menstrual care, menopause solutions, pregnancy trackers, diagnostics and reproductive health.

PHASE Scientific, which previously received a grant from the US Department of Health and Human Services, announced a $34M USD Series A Round from a HK asset management firm in 2025. This company has created at-home testing with an easy-to-use vaginal swab to check for three common vaginal infections: Bacterial Vaginosis, Candidiasis (yeast infection) and Trichomoniasis.

Overseas investment also supported Amma Pregnancy Tracker, a digital platform providing evidence-based pregnancy information and personalised recommendations, which received $250K USD in investment from US venture capital fund SOSV.

Zhu Yihan (Femtech Weekend) and Maaike Steinebach (Femtech Future) shared about the Greater Bay Area (GBA) as a national economic development initiative that integrates 11 cities in southern China into a unified innovation and business ecosystem. The GBA is being positioned as China’s premier high-tech and open-market region, with strong links to global finance, biotech, and manufacturing. For new entrants to China’s women’s health innovation market, the GBA may offer a more attractive launchpad than traditional hubs like Beijing or Shanghai. China is a strong innovation partner. Amma also participated in the 19th cohort of SOSV’s Shanghai-based cross-border accelerator, Chinaccelerator.

Hong Kong Science & Technology Park (HKSTP) works closely with Shenzhen, widely known as “China’s Silicon Valley” due to its thriving high-tech industry and rapid growth as a global technology hub.

The HKSTP Shenzhen Branch is a collaboration by HK and Shenzhen governments to foster connectivity between HK, Mainland China and global markets.

HKSTP supports the entire start-up lifecycle, including development funding. HKSTP Venture Fund invests directly in startups from seed to pre-IPO stage and partners with private investors for co-investments. WomenX Biotech, which has created a non-invasive blood test that can detect HPV - benefitted from this incubation programme and network.

EggLogics, a startup optimising the IVF process, took part in the 2023 HKTDC (Hong Kong Trade Development Council) Start-up Express programme for HK-based startups to gain exposure, mentorship and connections.

With much support from the ecosystem, FemTech Association Asia expects to see more startups launched, innovations commercialised and funding activity in Hong Kong in the years ahead.and rapid growth as a global technology hub.

List excludes: Individual Angels and Family Office investors. Companies like Amma Pregnancy Tracker, Luuna, Nancy, among others have secured private and/or undisclosed investment.